A group sequential approach to evaluation of bridging studies

Journal of Biopharmaceutical Statistics

Volumn 13, Issue 4, 2003, Pages 793-801

  Hsiao, Chin Fu ^a   Xu, Jia Zhen ^a   Liu, Jen pei ^a,b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Bridging study; Extrapolation; Group sequential analysis; Similarity

Indexed keywords

ARTICLE; CALCULATION; DATA ANALYSIS; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; EVALUATION; INFORMATION PROCESSING; MATHEMATICAL ANALYSIS; MEASUREMENT; METHODOLOGY; OUTCOMES RESEARCH; PHARMACODYNAMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SAMPLE SIZE; SEQUENTIAL ANALYSIS; STATISTICAL ANALYSIS; TECHNIQUE; VALIDATION PROCESS;

BIOPHARMACEUTICS; CLINICAL TRIALS; MODELS, STATISTICAL; SAMPLE SIZE;

EID: 0141889798     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-120024210     Document Type: Article

References (11)

1. Chow, S. C., Shao, J., Hu, O. Y. P. (2002). Assessing sensitivity and similarity in bridging studies. J. Biopharmaceutical Statistics 12:385-400.
2. Cui, L., Hung, H. M. J., Wang, S.-J (1999). Modification of sample size in group sequential clinical trials. Biometrics 55:853-857.
3. ICH, International Conference on Harmonisation (1998). Tripartite Guidance E5 Ethnic Factors in the Acceptability of Foreign Data, The U.S. Federal Register, 83, 31,790-31,796.
4. Lan, K. K. G., DeMets, D. L. (1983). Discrete sequential boundaries for clinical trials. Biometrika 70:659-663.
5. Lan, K. K. G., Trost, D. C. (1997). Estimation of parameters and sample size reestimation. In: Proceedings of Biopharmaceutical Section, American Statistical Association.
6. Lan, K. K. G., Simon, R., Halperin, M. (1982). Stochastically curtailed tests in long-term clinical trials. Communications in Statistics C1, 207-219.
7. Liu, J. P., Chow, S. C. (2002). Bridging studies for clinical development. J. Biopharmaceutical Statistics 12:357-369.
8. Liu, J. P., Hsiao, C.-F., Hsueh, H.-M. (2002a). Bayesian approach to evaluation of bridging studies. J. Biopharmaceutical Statistics 12:401-408.
9. Liu, J. P., Hsueh, H.-M., Chen, J. J. (2002b). Sample size requirement for evaluation of bridging evidence. Biometrical Journal 44:969-981.
10. Liu, J. P., Hsueh, H.-M, Hsiao, C.-F. (2003). Bayesian non-inferiority approach to evaluation of bridging studies. J. Biopharmaceutical statistics, in press.
11. Shih, W. J. (2001). Clinical trials for drug registration in Asian-Pacific countries: proposal for a new paradigm from a statistical perspective. Controlled Clinical Trials 22:357-366.